Question 1

Does Alyeska Investment Group own PRAX stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Alyeska Investment Group holds 80,846 shares of PRAX (Praxis Precision Medicines), worth $27.1M.

Question 2

How many shares of PRAX does Alyeska Investment Group own?

Accepted Answer

As of its Q2 2026 13F, Alyeska Investment Group holds 80,846 shares of PRAX (Praxis Precision Medicines).

Question 3

What is Alyeska Investment Group's PRAX position worth?

Accepted Answer

As of its Q2 2026 13F, Alyeska Investment Group's PRAX position is worth $27.1M.

Question 4

Is Alyeska Investment Group buying or selling PRAX?

Accepted Answer

In Q2 2026, Alyeska Investment Group increased its PRAX position by 8,668 shares (+12.0%).

Question 5

When did Alyeska Investment Group first buy PRAX?

Accepted Answer

Alyeska Investment Group first reported PRAX in its Q1 2024 13F and has listed it in 8 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	80,846	+12.0%	$27.1M	0.1%	$334.79	32
2026-Q1	Decreased	72,178	-3.0%	$23.3M	0.1%	$318.22	0
2025-Q4	Decreased	74,376	-47.4%	$21.9M	0.1%	$297.02	0
2025-Q3	Increased	141,516	+13.2%	$7.5M	0.0%	$52.38	31
2025-Q2	Decreased	125,000	-16.7%	$5.3M	0.0%	$43.00	0
2025-Q1	Decreased	150,000	-33.9%	$5.7M	0.0%	$38.66	0
2024-Q4	New	226,788	—	$17.5M	0.1%	$76.26	39